WEF Davos 2018: Launching the ‘Antimicrobial Resistance Benchmark’

| By | Antimicrobial Resistance, Pharmaceutical Industry

The 48th World Economic Forum (WEF) Annual Meeting started in Davos, Switzerland. It aims to rededicate leaders from all walks of life to developing a shared narrative to improve the state of the world. 

The Access to Medicine Foundation launched the benchmark that tracks the actions of drug industry efforts to combat the drug resistance.

More than 700,000 people already die every year from drug-resistant bacterial infections. Unless action is taken, this number will reach 10 million people a year worldwide by 2050 (more than currently die from cancer). Pharmaceutical companies, together with governments and other stakeholders, have a crucial role in preventing this scenario.

The first-ever Antimicrobial Resistance Benchmark will map the actions of 30 pharmaceutical companies across three research areas: Research & Development, Manufacturing and Production, Access & Stewardship. The Benchmark will show where the pharmaceutical industry is taking action, which companies are leading, and where faster progress is needed.

Full methodology for Antimicrobial Resistance Benchmark can be seen here.